Steven Cohen’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
Other funds holding LXEO
Steven Cohen's LXEO Position: Q3 2026 in Review
Steven Cohen opened a new position in Lexeo Therapeutics (LXEO) in Q3 2026: 447,197 shares worth $1.51M. The stake represents ﹤0.01% of the portfolio and ranks #2576 among its holdings. This is a return to the name: Steven Cohen previously reported a position in LXEO as recently as Q1 2026.
Steven Cohen first reported a position in LXEO in Q3 2024 and has held it in 8 quarters since. The position peaked at $18.8M in Q4 2025. 153 funds tracked by Wall St. Rank hold LXEO as of Q3 2026.
- Steven Cohen held 447,197 shares of Lexeo Therapeutics worth $1.51M as of Q3 2026.
- Lexeo Therapeutics was a new Steven Cohen position in Q3 2026.
- Lexeo Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2576 holding.
- Steven Cohen first reported a position in Lexeo Therapeutics in Q3 2024 and has held it in 8 quarters since.
- Steven Cohen's Lexeo Therapeutics position peaked at $18.8M in Q4 2025.
- 153 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.